View Item 

Show simple item record

Clinical and biochemical profiles suggest fibromuscular dysplasia is a systemic disease with altered TGFâ β expression and connective tissue features
dc.contributor.authorGanesh, Santhi K.
dc.contributor.authorMorissette, Rachel
dc.contributor.authorXu, Zhi
dc.contributor.authorSchoenhoff, Florian
dc.contributor.authorGriswold, Benjamin F.
dc.contributor.authorYang, Jiandong
dc.contributor.authorTong, Lan
dc.contributor.authorYang, Min‐lee
dc.contributor.authorHunker, Kristina
dc.contributor.authorSloper, Leslie
dc.contributor.authorKuo, Shinie
dc.contributor.authorRaza, Rafi
dc.contributor.authorMilewicz, Dianna M.
dc.contributor.authorFrancomano, Clair A.
dc.contributor.authorDietz, Harry C.
dc.contributor.authorVan Eyk, Jennifer
dc.contributor.authorMcDonnell, Nazli B.
dc.date.accessioned2020-03-17T18:30:38Z
dc.date.available2020-03-17T18:30:38Z
dc.date.issued2014-08
dc.identifier.citationGanesh, Santhi K.; Morissette, Rachel; Xu, Zhi; Schoenhoff, Florian; Griswold, Benjamin F.; Yang, Jiandong; Tong, Lan; Yang, Min‐lee ; Hunker, Kristina; Sloper, Leslie; Kuo, Shinie; Raza, Rafi; Milewicz, Dianna M.; Francomano, Clair A.; Dietz, Harry C.; Van Eyk, Jennifer; McDonnell, Nazli B. (2014). "Clinical and biochemical profiles suggest fibromuscular dysplasia is a systemic disease with altered TGFâ β expression and connective tissue features." The FASEB Journal 28(8): 3313-3324.
dc.identifier.issn0892-6638
dc.identifier.issn1530-6860
dc.identifier.urihttps://hdl.handle.net/2027.42/154380
dc.publisherThe Federation of American Societies for Experimental Biology
dc.publisherWiley Periodicals, Inc.
dc.subject.otherbiomarker
dc.subject.otherFMD
dc.subject.otherTGFâ β
dc.subject.otherpathway aneurysm · human genetics
dc.titleClinical and biochemical profiles suggest fibromuscular dysplasia is a systemic disease with altered TGFâ β expression and connective tissue features
dc.typeArticle
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelBiology
dc.subject.hlbtoplevelScience
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/154380/1/fsb2028008005.pdf
dc.identifier.doi10.1096/fj.14-251207
dc.identifier.sourceThe FASEB Journal
dc.identifier.citedreferenceGabay, C., and Kushner, I. ( 1999 ) Acuteâ phase proteins and other systemic responses to inflammation. N. Engl. J. Med. 340, 448 â 454
dc.identifier.citedreferenceOlin, J. W. ( 2012 ) Is fibromuscular dysplasia a single disease? Circulation 126, 2925 â 2927
dc.identifier.citedreferenceSavard, S., Steichen, O., Azarine, A., Azizi, M., Jeunemaitre, X., and Plouin, P. F. ( 2012 ) Association between 2 angiographic subtypes of renal artery fibromuscular dysplasia and clinical characteristics. Circulation 126, 3062 â 3069
dc.identifier.citedreferenceTanaka, T., Scheet, P., Giusti, B., Bandinelli, S., Piras, M. G., Usala, G., Lai, S., Mulas, A., Corsi, A. M., Vestrini, A., Sofi, F., Gori, A. M., Abbate, R., Guralnik, J., Singleton, A., Abecasis, G. R., Schlessinger, D., Uda, M., and Ferrucci, L. ( 2009 ) Genomeâ wide association study of vitamin B6, vitamin B12, folate, and homocysteine blood concentrations. Am. J. Hum. Genet. 84, 477 â 482
dc.identifier.citedreferenceMilhorat, T. H., Bolognese, P. A., Nishikawa, M., McDonnell, N. B., and Francomano, C. A. ( 2007 ) Syndrome of occipitoatâ lantoaxial hypermobility, cranial settling, and Chiari malformation type I in patients with hereditary disorders of connective tissue. J. Neurosurg. Spine 7, 601 â 609
dc.identifier.citedreferenceNormand, J., and Karasek, M. A. ( 1995 ) A method for the isolation and serial propagation of keratinocytes, endothelial cells, and fibroblasts from a single punch biopsy of human skin. In Vitro Cell. Dev. Biol. Anim. 31, 447 â 455
dc.identifier.citedreferenceTanner, F. C., Yang, Z. Y., Duckers, E., Gordon, D., Nabel, G. J., and Nabel, E. G. ( 1998 ) Expression of cyclinâ dependent kinase inhibitors in vascular disease. Circ. Res. 82, 396 â 403
dc.identifier.citedreferenceOlin, J. W., Froehlich, J., Gu, X., Bacharach, J. M., Eagle, K., Gray, B. H., Jaff, M. R., Kim, E. S., Mace, P., Matsumoto, A. H., McBane, R. D., Klineâ Rogers, E., White, C. J., and Gornik, H. L. ( 2012 ) The United States registry for fibromuscular dysplasia: results in the first 447 patients. Circulation 125, 3182 â 3190
dc.identifier.citedreferencePoloskey, S. L., Kim, E. S. H., Sanghani, R., Alâ Quthami, A. H., Arscott, P., Moran, R., Rigelsky, C. M., and Gornik, H. L. ( 2012 ) Low yield of genetic testing for known vascular connective tissue disorders in patients with fibromuscular dysplasia. Vasc. Med. 17, 371 â 378
dc.identifier.citedreferenceBoden, S. D., Davis, D. O., Dina, T. S., Patronas, N. J., and Wiesel, S. W. ( 1990 ) Abnormal magneticâ resonance scans of the lumbar spine in asymptomatic subjects: a prospective investigation. J. Bone Joint Surg. Am. 72, 403 â 408
dc.identifier.citedreferenceBoden, S. D., McCowin, P. R., Davis, D. O., Dina, T. S., Mark, A. S., and Wiesel, S. ( 1990 ) Abnormal magneticâ resonance scans of the cervical spine in asymptomatic subjects: a prospective investigation. J. Bone Joint Surg. Am. 72, 1178 â 1184
dc.identifier.citedreferenceDolan, A. L., Hart, D. J., Doyle, D. V., Grahame, R., and Spector, T. D. ( 2003 ) The relationship of joint hypermobility, bone mineral density, and osteoarthritis in the general population: the Chingford Study. J. Rheumatol. 30, 799 â 803
dc.identifier.citedreferenceHakim, A. J., Cherkas, L. F., Grahame, R., Spector, T. D., and MacGregor, A. J. ( 2004 ) The genetic epidemiology of joint hypermobility: a population study of female twins. Arthritis Rheum. 50, 2640 â 2644
dc.identifier.citedreferenceMatt, P., Schoenhoff, F., Habashi, J., Holm, T., Van Erp, C., Loch, D., Carlson, O. D., Griswold, B. F., Fu, Q., De Backer, J., Loeys, B., Huso, D. L., McDonnell, N. B., Van Eyk, J. E., and Dietz, H. C. ( 2009 ) Circulating transforming growth factorâ beta in Marfan syndrome. Circulation 120, 526 â 532
dc.identifier.citedreferenceRodrigues, V. J., Elsayed, S., Loeys, B. L., Dietz, H. C., and Yousem, D. M. ( 2009 ) Neuroradiologic manifestations of Loeysâ Dietz syndrome type 1. Am. J. Neuroradiol. 30, 1614 â 1619
dc.identifier.citedreferenceRose, P. S., Levy, H. P., Ahn, N. U., Sponseller, P. D., Magyari, T., Davis, J., and Francomano, C. A. ( 2000 ) A comparison of the Berlin and Ghent nosologies and the influence of dural ectasia in the diagnosis of Marfan syndrome. Genet. Med. 2, 278 â 282
dc.identifier.citedreferenceArnett, D. K., Jacobs, D. R., Jr., Luepker, R. V., Blackburn, H., Armstrong, C., and Claas, S. A. ( 2005 ) Twentyâ year trends in serum cholesterol, hypercholesterolemia, and cholesterol medication use: the Minnesota Heart Survey, 1980â 1982 to 2000â 2002. Circulation 112, 3884 â 3891
dc.identifier.citedreferenceD’Anglejan Chatillon, J., Ribeiro, V., Mas, J. L., Bousser, M. G., and Laplane, D. ( 1990 ) [Dissection of the extracranial internal carotid artery. 62 cases.] Presse Méd. 19, 661 â 667
dc.identifier.citedreferenceMas, J. L., Bousser, M. G., Hasboun, D., and Laplane, D. ( 1987 ) Extracranial vertebral artery dissections: a review of 13 cases. Stroke 18, 1037 â 1047
dc.identifier.citedreferenceShultz, S. J., Gansneder, B. M., Sander, T. C., Kirk, S. E., and Perrin, D. H. ( 2006 ) Absolute serum hormone levels predict the magnitude of change in anterior knee laxity across the menstrual cycle. J. Orthop. Res. 24, 124 â 131
dc.identifier.citedreferenceKisilevsky, R., and Manley, P. N. ( 2012 ) Acuteâ phase serum amyloid A: perspectives on its physiological and pathological roles. Amyloid 19, 5 â 14
dc.identifier.citedreferenceNabel, E. G., Shum, L., Pompili, V. J., Yang, Z. Y., San, H., Shu, H. B., Liptay, S., Gold, L., Gordon, D., and Derynck, R. ( 1993 ) Direct transfer of transforming growth factor beta 1 gene into arteries stimulates fibrocellular hyperplasia. Proc. Natl. Acad. Sci. U.S.A. 90, 10759 â 10763
dc.identifier.citedreferenceErkula, G., Sponseller, P. D., Paulsen, L. C., Oswald, G. L., Loeys, B. L., and Dietz, H. C. ( 2010 ) Musculoskeletal findings of Loeysâ Dietz syndrome. J. Bone Joint Surg. Am. 92, 1876 â 1883
dc.identifier.citedreferenceLoeys, B. L., Chen, J., Neptune, E. R., Judge, D. P., Podowski, M., Holm, T., Meyers, J., Leitch, C. C., Katsanis, N., Sharifi, N., Xu, F. L., Myers, L. A., Spevak, P. J., Cameron, D. E., De Backer, J., Hellemans, J., Chen, Y., Davis, E. C., Webb, C. L., Kress, W., Coucke, P., Rifkin, D. B., De Paepe, A. M., and Dietz, H. C. ( 2005 ) A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2. Nat. Genet. 37, 275 â 281
dc.identifier.citedreferenceWrana, J. L., Attisano, L., Wieser, R., Ventura, F., and Massague, J. ( 1994 ) Mechanism of activation of the TGFâ beta receptor. Nature 370, 341 â 347
dc.identifier.citedreferenceLing, S., Nheu, L., and Komesaroff, P. A. ( 2012 ) Cell adhesion molecules as pharmaceutical target in atherosclerosis. Mini. Rev. Med. Chem. 12, 175 â 183
dc.identifier.citedreferenceKoch, A. E., Polverini, P. J., Kunkel, S. L., Harlow, L. A., Di Pietro, L. A., Elner, V. M., Elner, S. G., and Strieter, R. M. ( 1992 ) Interleukinâ 8 as a macrophageâ derived mediator of angiogenesis. Science 258, 1798 â 1801
dc.identifier.citedreferenceLi, A., Dubey, S., Varney, M. L., Dave, B. J., and Singh, R. K. ( 2003 ) ILâ 8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis. J. Immunol. 170, 3369 â 3376
dc.identifier.citedreferenceSmith, W. B., Noack, L., Khewâ Goodall, Y., Isenmann, S., Vadas, M. A., and Gamble, J. R. ( 1996 ) Transforming growth factorâ beta 1 inhibits the production of ILâ 8 and the transmigration of neutrophils through activated endothelium. J. Immunol. 157, 360 â 368
dc.identifier.citedreferenceMorissette, R., Schoenhoff, F., Xu, Z., Shilane, D. A., Griswold, B. F., Chen, W., Yang, J., Zhu, J., Fertâ Bober, J., Sloper, L., Lehman, J., Commins, N., Van Eyk, J. E., and McDonnell, N. B. ( 2014 ) Transforming growth factorâ beta and inflammation in vascular (type IV) Ehlersâ Danlos syndrome. Circ. Cardiovasc. Genet. 7, 80 â 88
dc.identifier.citedreferenceAkhurst, R. J. ( 2012 ) The paradoxical TGFâ beta vasculopathies. Nat. Genet. 44, 838 â 839
dc.identifier.citedreferenceDoyle, A. J., Doyle, J. J., Bessling, S. L., Maragh, S., Lindsay, M. E., Schepers, D., Gillis, E., Mortier, G., Homfray, T., Sauls, K., Norris, R. A., Huso, N. D., Leahy, D., Mohr, D. W., Caulfield, M. J., Scott, A. F., Destree, A., Hennekam, R. C., Arn, P. H., Curry, C. J., Van Laer, L., McCallion, A. S., Loeys, B. L., and Dietz, H. C. ( 2012 ) Mutations in the TGFâ beta repressor SKI cause Shprintzenâ Goldberg syndrome with aortic aneurysm. Nat. Genet. 44, 1249 â 1254
dc.identifier.citedreferenceSt Hilaire, C., Ziegler, S. G., Markello, T. C., Brusco, A., Groden, C., Gill, F., Carlsonâ Donohoe, H., Lederman, R. J., Chen, M. Y., Yang, D., Siegenthaler, M. P., Arduino, C., Mancini, C., Freudenthal, B., Stanescu, H. C., Zdebik, A. A., Chaganti, R. K., Nussbaum, R. L., Kleta, R., Gahl, W. A., and Boehm, M. ( 2011 ) NT5E mutations and arterial calcifications. N. Engl. J. Med. 364, 432 â 442
dc.identifier.citedreferenceAoyama, T., Francke, U., Gasner, C., and Furthmayr, H. ( 1995 ) Fibrillin abnormalities and prognosis in Marfan syndrome and related disorders. Am. J. Med. Genet. 58, 169 â 176
dc.identifier.citedreferenceTanemoto, M., Takase, K., Yamada, T., Satoh, A., Abe, T., and Ito, S. ( 2007 ) Dilation of renal artery stenosis after administration of losartan. Hypertens. Res. 30, 999 â 1002
dc.identifier.citedreferenceLeadbetter, W. F., and Burkland, C. F. ( 1938 ) Hypertension in unilateral renal disease. J. Urol. 39, 611 â 626
dc.identifier.citedreferenceSlovut, D. P., and Olin, J. W. ( 2004 ) Fibromuscular dysplasia. N. Engl. J. Med. 350, 1862 â 1871
dc.identifier.citedreferenceHarrison, E. G., Jr., and McCormack, L. J. ( 1971 ) Pathologic classification of renal arterial disease in renovascular hypertension. Mayo Clin. Proc. 46, 161 â 167
dc.identifier.citedreferenceStanley, J. C., and Fry, W. J. ( 1975 ) Renovascular hypertension secondary to arterial fibrodysplasia in adults: criteria for operation and results of surgical therapy. Arch. Surg. 110, 922 â 928
dc.identifier.citedreferenceOlin, J. W., and Sealove, B. A. ( 2011 ) Diagnosis, management, and future developments of fibromuscular dysplasia. J. Vasc. Surg. 53, 826 â 836, e821
dc.identifier.citedreferenceStanley, J. C., Gewertz, B. L., Bove, E. L., Sottiurai, V., and Fry, W. J. ( 1975 ) Arterial fibrodysplasia: histopathologic character and current etiologic concepts. Arch. Surg. 110, 561 â 566
dc.identifier.citedreferenceStanley, J. C., and Whitehouse, W. M., Jr. ( 1984 ) Occlusive and aneurysmal disease of the renal arterial circulation. Dis. Mon. 30, 1 â 62
dc.identifier.citedreferenceWynn, T. A. ( 2008 ) Cellular and molecular mechanisms of fibrosis. J. Pathol. 214, 199 â 210
dc.identifier.citedreferenceGladstien, K., Rushton, A. R., and Kidd, K. K. ( 1980 ) Penetrance estimates and recurrence risks for fibromuscular dysplasia. Clin. Genet. 17, 115 â 116
dc.identifier.citedreferenceSchievink, W. I., and Limburg, M. ( 1989 ) Angiographic abnormalities mimicking fibromuscular dysplasia in a patient with Ehlersâ Danlos syndrome, type IV. Neurosurgery 25, 482 â 483
dc.identifier.citedreferenceMilewicz, D. M., Kwartler, C. S., Papke, C. L., Regalado, E. S., Cao, J., and Reid, A. J. ( 2010 ) Genetic variants promoting smooth muscle cell proliferation can result in diffuse and diverse vascular diseases: evidence for a hyperplastic vasculomyopathy. Genet. Med. 12, 196 â 203
dc.identifier.citedreferenceLancman, M., Mesropian, H., Serra, P., and Granillo, R. ( 1991 ) Turner’s syndrome, fibromuscular dysplasia, and stroke. Stroke 22, 269 â 271
dc.identifier.citedreferenceSchievink, W. I., Bjornsson, J., and Piepgras, D. G. ( 1994 ) Coexistence of fibromuscular dysplasia and cystic medial necrosis in a patient with Marfan’s syndrome and bilateral carotid artery dissections. Stroke 25, 2492 â 2496
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
fsb2028008005.pdf
Size:
321.9KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.